Spark Therapeutics
Gene therapy biotechnology company developing treatments for genetic diseases using AAV-based gene therapies, focusing on inherited retinal diseases, neurodegenerative conditions, and hemophilia, acquired by Roche in 2019.
About
What Spark Therapeutics is
Gene therapy biotechnology company developing treatments for genetic diseases using AAV-based gene therapies, focusing on inherited retinal diseases, neurodegenerative conditions, and hemophilia, acquired by Roche in 2019.
losclouds keeps public details for this profile. There are no catalog offerings to compare yet.
EnterpriseHealthcare
At a glance
| Fact | Value |
|---|---|
| Official site | https://sparktherapeutics.com |
| Status coverage | Public status page |
| Parent company | Roche |
| Founded | 2013 |
| Headquarters | Philadelphia, Pennsylvania, United States |
| Categories | Enterprise, Healthcare |
Loading offerings...